2021
DOI: 10.1002/prp2.732
|View full text |Cite
|
Sign up to set email alerts
|

Chronic everolimus treatment of high‐fat diet mice leads to a reduction in obesity but impaired glucose tolerance

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 57 publications
1
2
0
Order By: Relevance
“…The exposure of diets extended for 12 weeks and were administered during adulthood. This dietary duration is consistent with other studies examining impacts of long-term high-fat and/or chronic sucrose interventions on rodent physiology ( Aoi et al, 2011 ; Chang et al, 2021 ; Odom et al, 2021 ). It was interesting, although not altogether unexpected, that the HS diet did not cause significant weight gain.…”
Section: Discussionsupporting
confidence: 90%
“…The exposure of diets extended for 12 weeks and were administered during adulthood. This dietary duration is consistent with other studies examining impacts of long-term high-fat and/or chronic sucrose interventions on rodent physiology ( Aoi et al, 2011 ; Chang et al, 2021 ; Odom et al, 2021 ). It was interesting, although not altogether unexpected, that the HS diet did not cause significant weight gain.…”
Section: Discussionsupporting
confidence: 90%
“…Of note is the comparison between the CMG and CEG schemes, which showed more numerous and more prominent VDs in the hepatocytes of rats exposed to the protocol including EVE, which is an mTOR inhibitor. Regarding other pathological alterations, according to Chang et al [52], EVE usage in mice resulted in decreased weight of the liver with a lowered accumulation of fat. There is data indicating that mTOR inhibitors increase the mortality of a fetus in animals.…”
Section: Discussionmentioning
confidence: 98%
“…Generally, a reduction in Akt phosphorylation and serum FGF21 level leads to the attenuation of insulin signaling, which impairs glucose homeostasis and enhances IR [33,39]. GLUT4 facilitates insulin-promoted glucose uptake into adipose tissue and muscle, and reduced GLUT4 expression levels lower insulin-mediated glucose uptake; exacerbated hyperglycemia may be the mechanism of action, as indicated by heightened glucose intolerance on the basis of an IPGTT [70]. Considerable basal glucose transport reductions suggest strong IR and glucose intolerance in mice that have diabetes and a selective deficiency of GLUT4 in their muscles [33].…”
Section: Discussionmentioning
confidence: 99%